TY  - ADVS
AU  - Lapteva,Larissa
TI  - Development and regulation of cellular and gene therapy products: FDA perspective 
T2  - The biomedical & life sciences collection,
PY  - 2021///
CY  - London
PB  - Henry Stewart Talks
KW  - United States
KW  - Food and Drug Administration
KW  - Cellular therapy
KW  - Law and legislation
KW  - Moral and ethical aspects
KW  - Gene therapy
KW  - Human genetics
KW  - Government policy
KW  - Stem cells
KW  - Therapeutic use
KW  - Cell- and Tissue-Based Therapy
KW  - ethics
KW  - standards
KW  - Genetic Therapy
KW  - legislation & jurisprudence
KW  - United States Food and Drug Administration
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Contents: Cellular and gene therapy products -- U.S. laws and regulations -- FDA review -- Product development considerations -- Regulatory considerations -- Product manufacturing stages and quality testing -- Safety, efficacy and ethical considerations for clinical program design -- FDA Guidance documents; Access restricted to subscribers
UR  - https://hstalks.com/bs/4793/
ER  -